MUC Research

MUC Research is a specialized clinical research organization (CRO) and medical research center located in Munich, Germany. The company focuses primarily on infectious diseases, with a world-class reputation in the management of HIV/AIDS and viral hepatitis (HBV, HCV, and HDV) clinical trials. They provide a full range of services for Phase I through IV clinical studies, including patient recruitment, trial monitoring, and data management. Beyond interventional drug trials, MUC Research is a key contributor to significant epidemiological studies and long-term observational cohorts. The center collaborates extensively with global pharmaceutical leaders and academic institutions to evaluate novel antiviral therapies and vaccines. Their expertise also extends to respiratory viruses, having played a significant role in COVID-19 therapeutic research during the pandemic.